An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three Weeks
Clinical trial NCT00338416 · COMPLETED
Trial details
- NCT number
- NCT00338416
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.